secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardian Pharmacy Services, Inc. (GRDN)
CIK:        0001802255
Form:       8-K
Filed at:   2026-01-13T23:59:59+00:00
Accession:  0001193125-26-011826
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guardian reiterates 2025 guidance, provides 2026 outlook with ~11% adj. EBITDA growth
--------------------------------------------------------------------------------

- Reaffirmed 2025 revenue $1.43B-$1.45B and adjusted EBITDA $104M-$106M.
- 2026 outlook: revenue $1.40B-$1.42B (down due to IRA drug price cuts) and adjusted EBITDA $115M-$118M.
- 2026 adjusted EBITDA margin expected above 8%, structural improvement from 2025.
- Completed year-end acquisition of a single pharmacy in Montana, adding new territory.
- CEO expects low double-digit adjusted EBITDA growth despite mandatory price reductions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802255/000119312526011826/0001193125-26-011826-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802255/000119312526011826/d824523d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-011826

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer